Deferataj 250mg Tablet DT
Marketer
Taj Pharma India Ltd
Salt Composition
Deferasirox (250mg)
Overview Deferataj 250mg Tablet DT
Chronic iron overload from repeated blood transfusions is treated with Deferataj 250mg Tablet DT. This medication facilitates iron excretion, mitigating potential organ damage. Administer Deferataj 250mg Tablet DT on an empty stomach, adhering strictly to prescribed dosage and schedule for optimal efficacy. Common adverse effects include nausea, headache, constipation, and diarrhea. Report persistent or worsening side effects to your physician. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and provide a complete list of all concurrently used medications to your doctor for safety evaluation.
Uses of Deferataj 250mg Tablet DT
Managing excess iron in the body
Major Benefits of Deferataj 250mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Deferataj 250mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Deferataj 250mg Tablet DT:
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Abdominal distension
- Diarrhea
How to use Deferataj 250mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Deferataj 250mg Tablet DT in water before consumption. Administer on an empty stomach.
How Deferataj 250mg Tablet DT works:
Deferasirox 250mg Delayed-Release Tablets bind and eliminate surplus iron, primarily expelled through bowel movements. This mitigates the potential for organ harm.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Deferataj 250mg Tablet DT is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Deferataj 250mg Tablet DT during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Deferataj 250mg Tablet DT while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Deferataj 250mg Delayed-Release Tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyUNSAFE
The use of Deferataj 250mg Tablet DT is likely inadvisable for individuals with impaired kidney function and should be omitted. Medical advice is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Deferataj 250mg Tablet DT. Dosage modification of Deferataj 250mg Tablet DT might be necessary. Physician consultation is advised.
What if you forget to take Deferataj 250mg Tablet DT :
Should you forget a Deferataj 250mg Tablet DT dose, administer it immediately if feasible. Otherwise, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Deferataj 250mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Benzoate-triazole hybrid |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently